House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Pain medicine · Oncology · Palliative care

Use of opioids for adults with pain from cancer or cancer treatment

ASCO · 2023 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

This focused society news report describes selected recommendations from the ASCO guideline for opioid treatment of adult pain caused by cancer or its treatment. It includes interviews with the guideline co-chairs; the summary below uses the recommendations explicitly attributed to the guideline rather than treating every interview comment as formal guidance.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Offer treatment and agree goals

  • Offer an FDA-approved opioid for moderate-to-severe cancer-related pain unless it is contraindicated. The report describes this recommendation in the context of adults with pain from cancer or cancer treatment. [1]
  • Discuss expectations and concerns with the patient and caregivers. Include education about adverse effects, ways to address them, and how the care team will monitor and manage them. [1]

Start carefully and obtain specialist support

  • Start with the lowest opioid dose that achieves acceptable analgesia and meets the patient’s goals. [1]
  • For initial treatment, use an immediate-release, fast-acting, short-lasting opioid on an as-needed basis, followed by early reassessment. [1]
  • For a patient with a substance use disorder, involve a palliative-care, pain or substance-use-disorder specialist in opioid management. [1]

Limitations and use

  • This is a focused account of selected recommendations, not the full guideline or its complete evidence tables.
  • Individual opioid doses, conversion methods, organ-impairment adjustments, breakthrough-pain regimens and detailed adverse-effect protocols are not supplied here.
  • Interview commentary about mild pain or a particular initiation interval has not been presented as a formal guideline recommendation.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Use of opioids for adults with pain from cancer or cancer treatment

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
ASCO
First published
5 December 2022
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Offer treatment and agree goals
  • Start carefully and obtain specialist support
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House